Eltrombopag
Information about Eltrombopag
Eltrombopag Uses
Eltrombopag is used for chronic idiopathic thrombocytopenia and low platelet count due to ITP or HCV infection. It is used to treat low platelet count due to chronic immune (idiopathic) thrombocytopenic
purpura (ITP) or chronic hepatitis C virus (HCV) infection. It’s also used to treat severe aplastic anemia.
How Eltrombopag works
Eltrombopag is a thrombopoietin agonist. It works by stimulating the formation of new platelets in the blood. Platelets help to reduce or prevent bleeding.
Available Medicine for Eltrombopag
RevoladeNovartis India Ltd
₹0 to ₹156562 variant(s)
EltromagCipla Ltd
₹458 to ₹9172 variant(s)
TrombonatNatco Pharma Ltd
₹1312 to ₹23432 variant(s)
CelbopagCelon Laboratories Ltd
₹1156 to ₹21602 variant(s)
EltrogGlenmark Pharmaceuticals Ltd
₹750 to ₹15392 variant(s)
ThromplatAureate Healthcare Pvt Ltd
₹2343 to ₹42182 variant(s)
ElpagShilpa Medicare Ltd
₹782 to ₹15462 variant(s)
ElboromBDR Pharmaceuticals Internationals Pvt
₹1265 to ₹21932 variant(s)
EltrocibLucien Life Sciences Private Limited
₹1209 to ₹23432 variant(s)
RebopagMSN Laboratories
₹1546 to ₹53433 variant(s)
Expert advice for Eltrombopag
- Take Eltrombopag on an empty stomach, either 1 hour before or 2 hours after meals.
- Take Eltrombopag at least 2 hours before or 4 hours after eating dairy products and calcium-fortified juices.